Old Web
English
Sign In
Acemap
>
Paper
>
Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes.
Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes.
2021
Konstantinos Liapis
Vasileios Papadopoulos
George Vrachiolias
Athanasios Galanopoulos
Menelaos Papoutselis
Sotirios G. Papageorgiou
Panagiotis T. Diamantopoulos
Vassiliki Pappa
Nora-Athina Viniou
Alexandra Kourakli
Dimitris Τsokanas
Theodoros P. Vassilakopoulos
Eleftheria Hatzimichael
Eleni Bouronikou
Maria Ximeri
Charalambos Pontikoglou
Aekaterini Megalakaki
Panagiotis Zikos
Panayiotis Panayiotidis
Maria Dimou
Stamatis Karakatsanis
Maria Papaioannou
Anna Vardi
Flora N. Kontopidou
Nikolaos Harchalakis
Ioannis Adamopoulos
Argiris Symeonidis
Ioannis Kotsianidis
Keywords:
Myelodysplastic syndromes
Oncology
Medicine
Azacitidine
intermediate risk
Text mining
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
13
References
0
Citations
NaN
KQI
[]